Postdoctoral Research Associate

Research Interests:
Cancer cells has unique metabolic phenotype and respond differentially to various stimuli. Comprehensive understating of the epigenetic pathways that consort with metabolic reprogramming in cancer is not fully understood. We have observed that various carcinogens, metabolites and pharmaceutical inhibitors affects epigenetic reprogramming of the cancer cells. Ukti is investigating re-structuring of epigenetic and metabolic networks in prostate and bladder cancer cells and exploring reverting of onco-metabolic alterations.

Selected Publications:

  1. Ukti Bhatt, Upadhyayula Suryanarayana Murty, Subham Banerjee. Theoretical and experimental validation of praziquantel with different polymers for selection of an appropriate matrix for hot-melt extrusion. International Journal of Pharmaceutics, Volume 607, 2021, 120964, ISSN 0378-5173.

Ukti Bhatt, PhD

M.Sc., Gujrat, India

PhD, National Institute of Pharmaceutical Education and Research (NIPER)

Contact:

Email: ukti@wustl.edu

Phone: 314-273-7759